Company / Operating Income
Twist Bioscience Corp Operating Income History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$136.3M
FY2025
5-year range
-$234.8M / -$136.3M
FY2021-FY2025
Trend
+38.3%
vs FY2024
Sector context
#106 of 202
Health Care
What the data says
At -$136M, Twist Bioscience Corp's operating income ranks #106 of 202 in the Health Care sector. Operating Income has fluctuated over the past 9 years, ranging from -$235M in FY2022 to -$58M in FY2017.
Based on SEC 10-K filings.
-$136M in FY2025.
Improved from -$217M to -$136M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#106 of 202 in Health CareTop 52% of 202This company -$136.3M Sector average $86.7M
▼
-257.2% below sector average
Key checks
Key Insights
- In FY2025, operating income increased 38.3% year-over-year.
- Ranks #106 out of 202 companies in the Health Care sector.
- Peak operating income was recorded in FY2017.
- Lowest operating income in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$136.3M | +38.3% |
| FY2024 | -$220.8M | -1.7% |
| FY2023 | -$217.2M | +7.5% |
| FY2022 | -$234.8M | -53.7% |
| FY2021 | -$152.7M | -9.0% |
| FY2020 | -$140.1M | -28.7% |
| FY2019 | -$108.8M | -54.3% |
| FY2018 | -$70.6M | -20.7% |
| FY2017 | -$58.5M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026